Why Effective Participation Support Strategy is Critical to Trial Efficiency and Success in Rare Diseases
Trial participation exposes individuals to pressures that may become hurdles on the way to completing the study. This whitepaper from PRA’s Center for Rare Diseases addresses the challenges of understanding participation support and the methods used by PRA to overcome these barriers.
Rare Diseases and the Promise of Gene Therapy: What You Need to Know
The Center for Rare Diseases
We never forget that rare diseases alter entire lives—and we’re committed to changing that. Every day can be delayed, postponed, or canceled when…
Laura Iliescu, Manager of Patient Advocacy & Engagement, Center for Rare Diseases
We measure our HQ with actions, experiences, and intentions. Nowhere is that more evident that in the stories of our subject matter experts. We want…